About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Ranbaxy Gets USFDA Approval For Doxycycline Tablets

by Medindia Content Team on June 2, 2006 at 4:09 PM
Font : A-A+

Ranbaxy Gets USFDA Approval For Doxycycline Tablets

Ranbaxy Laboratories Ltd has received approval from USFDA for manufacturing and marketing Doxycycline Tablets in the US market.

The company informed the Bombay Stock Exchange that it got the approval for marketing the antibiotic in strengths of 50mg, 75mg and 100mg.

Advertisement

Doxycycline is indicated for a variety of infections caused by susceptible strains or micro-organisms including respiratory tract and urinary tract infections, skin and skin structure infections, it added.

The USFDA's office of Generic Drugs, has determined the company's formulations to be bioequivalent and having the same therapeutic effect as that of the branded drug Adoxa, marketed by Bioglan Pharmaceutical Co, Ranbaxy added.

Source:PTI News
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Vaccination  And Counter  Measures Against  Monkeypox
Indian Railways Special Concession on Health Grounds
COVID Toes
View all
Recommended Reading
News Archive
Date
Category
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Q Fever 

Most Popular on Medindia

Vent Forte (Theophylline) How to Reduce School Bag Weight - Simple Tips Daily Calorie Requirements The Essence of Yoga Accident and Trauma Care Blood Pressure Calculator Drug - Food Interactions Iron Intake Calculator Loram (2 mg) (Lorazepam) Nutam (400mg) (Piracetam)

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
CONSULT A DOCTOR